Cargando…
Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia
PURPOSE: Relapsed T-acute lymphoblastic leukemia (T-ALL) has limited treatment options. We investigated mechanisms of resistance to BH3 mimetics in T-ALL to develop rational combination strategies. We also looked at the preclinical efficacy of NWP-0476, a novel BCL-2/BCL-xL inhibitor, as single agen...
Autores principales: | Saygin, Caner, Giordano, Giorgia, Shimamoto, Kathryn, Eisfelder, Bart, Thomas-Toth, Anika, Venkataraman, Girish, Ananthanarayanan, Vijayalakshmi, Vincent, Tiffaney L., DuVall, Adam, Patel, Anand A., Chen, Yi, Tan, Fenlai, Anthony, Stephen P., Chen, Yu, Shen, Yue, Odenike, Olatoyosi, Teachey, David T., Kee, Barbara L., LaBelle, James, Stock, Wendy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10425730/ https://www.ncbi.nlm.nih.gov/pubmed/37363966 http://dx.doi.org/10.1158/1078-0432.CCR-23-0415 |
Ejemplares similares
-
OTS167 blocks FLT3 translation and synergizes with FLT3 inhibitors in FLT3 mutant acute myeloid leukemia
por: Eisfelder, Bartholomew J., et al.
Publicado: (2021) -
Efficacy and tolerability of a modified pediatric‐inspired intensive regimen for acute lymphoblastic leukemia in older adults
por: Patel, Anand Ashwin, et al.
Publicado: (2021) -
Network Analysis Reveals Synergistic Genetic Dependencies for Rational Combination Therapy in Philadelphia Chromosome–Like Acute Lymphoblastic Leukemia
por: Ding, Yang-Yang, et al.
Publicado: (2021) -
Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients
por: Saygin, Caner, et al.
Publicado: (2022) -
Defining and Treating Older Adults with Acute Myeloid Leukemia Who Are Ineligible for Intensive Therapies
por: Pettit, Kristen, et al.
Publicado: (2015)